Title
Category
Credits
Event date
Cost
  • NCPD/CNE
  • Participation
$0.00
Ali Shazib, DMD, will highlight the field of oral medicine and its integration into the oncology landscape (oral oncology), identify oral complications associated with cancer therapies, practical approaches towards managing oral complications, and discuss the role of multi-disciplinary care through going through cases. The presentation will include challenges associated with oral care for patients undergoing cancer therapy and its role in survivorship and beyond.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
Wendell Yarbrough, MD, MMHC, FACS, will lecture on multi-disciplinary treatment of head and neck cancer with updates regarding new techniques and treatment standards. This lecture will also give the audience updates on HPV-Associated Head and Neck Cancer with emerging therapeutic vulnerabilities. 
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
In this presentation, Dr. Bryant will share strategies in collaborating with team members in both the inpatient and outpatient settings to optimize cancer care.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
This is a case-based lecture to cover the common side effects and rare but important side effects of check point inhibitors and other immunotherapy agents.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
This lecture will provide an overview of the burden and outcomes of COVID-19 among patients living with cancer. We will also review the impact of the pandemic on cancer care delivery, and emerging data regarding vaccination safety and efficacy.
  • ACPE Pharmacist
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
This lecture will provide education on the safety and benefit of exercise during and after cancer treatment, resources that we have available at UNC and how you can help your patients implement exercise and wellness behaviors during and after their treatment.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
CAR-T therapy is expanding as a therapeutic option both in clinical trials and FDA approved commercial products for cancer patients.  This lecture will review the current treatments and their use in patients with hematologic malignancies.
  • NCPD/CNE
  • Participation
$0.00
This lecture will provide information to identify current and future cancer survivorship trends, use a framework to analyze survivors’ risks for long-term late effects and identify unmet needs, describe the APPs role in delivering follow-up/survivorship care and list survivorship resources.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
Genitourinary malignancies will account for approximately 20% of newly diagnosed cancers in 2021. Recent research advances in prostate, bladder, and kidney cancers utilizing new biomarkers and imaging tools, radiolabeled therapy, targeted therapy, immunotherapy and antibody-drug conjugates have led to new management approaches associated with significant improvements in patient outcomes.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
Immune Thrombocytopenic Purpura and Thrombotic Thrombocytopenic Purpura are both autoimmune conditions leading to low platelets, though the mechanism by which the platelets are consumed differs.  The lecture will update viewers on new therapies for the treatment of ITP and TTP

Pages